Topic: Diabetes Research Network
Conditions
Interventions
There will be a three month phase of treatment with either active (15 g soy protein with 66 mg phytoestrogen) or control (15 g soy protein alone). A bar containing 7.5 g isolated soy protein powder (S
Sponsors
Hull and East Yorkshire Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Diagnosis of type 2 diabetes 2. Patients will be on stable medication for their diabetes, hypertension, lipids and gout (if appropriate) for 3 months prior to entry into the study 3. Age between 45 - 75 years at the start of the study, male only 4. Serum testosterone value of 12 nmol/L or less (normal range 1236 nmol/L) and who are symptom free will be eligible to participate
Exclusion criteria
Exclusion criteria: 1. Patients with concurrent illness or any medication in the last 3 months 2. Patients not wishing to allow disclosure to their GPs 3. Patients who are taking hormone replacement therapy 4. Patients who are currently or have taken antibiotics in the last 3 months 5. Hba1c at recruiting stage of greater than 9% 6. Vegetarians 7. Smokers 8. Patients with known food allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantify the magnitude | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed